| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.3 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |